Peripheral Drug-Eluting Stent System Approved by NMPA

On November 11, 2020, CMDE granted the registration of the Peripheral Drug-Eluting Stent System produced by Zylox medical. The product dilates through balloon compression, mechanically dilating the narrow area of the blood vessel. At the same time, the rapid release of paclitaxel in the drug coating inhibited intimal hyperplasia. This product is expected to improve the long-term patency rate of target vessels and improve the quality of life of patients.

Link: https://www.nmpa.gov.cn/yaowen/ypjgyw/20201111163601166.html